Elevance Health Reports Q1 2026 Earnings with Strong EPS and Guidance Increase
Elevance Health (ELV) reported Q1 2026 earnings with adjusted diluted EPS of $12.58, including $1 per share from nonrecurring net investment income. The company raised its full-year adjusted EPS guidance to at least $26.75, citing improved claims experience and prudent assumptions. Membership reached 45.4 million, with growth in commercial and ACA Individual segments offset by declines in Medicare Advantage and Medicaid.
Topics: AI Investments Earnings EPS Guidance Expense Ratio Financial Results Membership Growth Operating Revenue